Mala Murthy - 24 Jun 2022 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role: CHIEF FINANCIAL OFFICER
Signature: /s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol: TDOC
Transactions as of: 24 Jun 2022
Transactions value $: -$151,242
Form type: 4
Filing time: 28 Jun 2022, 16:10:15 UTC
Previous filing: 03 Jun 2022
Next filing: 03 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TDOC	Common Stock	Options Exercise		+7.97K	+34.08%		31.3K	24 Jun 2022	Direct	F1
transaction	TDOC	Common Stock	Sale	-$151K	-4.05K	-12.93%	$37.32	27.3K	27 Jun 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TDOC	Restricted Stock Units	Options Exercise	$0	-7.97K	-100%	$0.00^*	0	24 Jun 2022	Common Stock	7.97K		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2	Shares sold to cover the issuer's withholding obligation in respect of reporting person's award.
F3	On June 24, 2019, the reporting person was granted 31,872 restricted stock units, vesting as to 25% of the shares on February 20, 2020 with the remainder of the shares vesting in three equal annual installments beginning on the first anniversary of the grant date.